Can inflammation or iron depletion cause reactive platelet elevation?

Platelets are increasingly recognized as dynamic cellular actors bridging the hematopoietic and immune systems, where reactive platelet elevation serves as a highly coordinated physiological response to systemic stress rather than an autonomous clonal event.

Mechanisms of reactive platelet production

• Cytokine and hormonal signaling: Systemic inflammation and immune activation release interleukin-6 (IL-6), which stimulates hepatic transcription of thrombopoietin (TPO). TPO binds to c-Mpl receptors on bone marrow megakaryocyte progenitors to drive their proliferation and platelet output.
• Iron-depletion pathways: Iron withdrawal removes a physiological brake on megakaryopoiesis, accelerating progenitor differentiation. Concurrently, hypoxia from severe iron deficiency elevates erythropoietin (EPO), which cross-reacts with megakaryocytic progenitors to further amplify production.

Immune communication and cellular crosstalk

• Innate immune sensing: Platelets express functional Toll-like receptors (TLR2, TLR4, TLR7, and TLR9). Receptor engagement triggers intracellular NF-κB and MAPK signaling pathways, inducing the synthesis and release of potent cytokines and chemokines such as IL-1β, CCL5, and CXCL4.
• Leukocyte engagement: Physical complexes form when platelet P-selectin binds leukocyte PSGL-1, activating leukocyte $\beta_2$-integrins. This interaction is stabilized by platelet GPIbα binding to leukocyte CD18/Mac-1, a physical crosstalk that promotes neutrophil extracellular trap (NET) formation and localized immunothrombotic feedback loops.

Bottom line

• Bottom line: Reactive platelet elevation is a highly regulated response to inflammation and iron depletion, producing platelets that actively orchestrate immune responses and leukocyte crosstalk far beyond basic hemostatic clotting.